Meier W, Meyer G
Frauenklinik, Ludwig-Maximilians-Universität München.
Geburtshilfe Frauenheilkd. 1990 May;50(5):414-6. doi: 10.1055/s-2008-1026273.
Most of the recurrences in patients with dysgerminoma occur, in more than 80%, in the first 2 years. Late recurrences are very rare. In this paper we report on a paraaortic recurrence, 12 years after primary therapy. Tumour biology and its influence on indication for surgery are discussed. Therapy of recurrence should be individualized including surgery, chemotherapy and radiotherapy. High remission rates in patients with recurrent dysgerminoma can be expected. In fact, our patient has been tumour-free for more than 5 years.
无性细胞瘤患者的复发大多（超过80%）发生在头两年。晚期复发非常罕见。在本文中，我们报告了1例在初次治疗12年后出现的主动脉旁复发。本文讨论了肿瘤生物学及其对手术指征的影响。复发性无性细胞瘤的治疗应个体化，包括手术、化疗和放疗。预计复发性无性细胞瘤患者有较高的缓解率。事实上，我们的患者已无瘤生存超过5年。
